SCHEMBL9370482

SCHEMBL9370482

COc1cc(C2CSCS2)cc(OC)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 2/20 0.46
ACHE P22303 3/20 0.44
PTPN1 P18031 1/20 0.44
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
TUBB4A P04350 5/20 0.41
TUBB P07437 5/20 0.41
TUBA3C P0DPH7 5/20 0.41
TUBA1B P68363 5/20 0.41
TUBA4A P68366 5/20 0.41
TUBB4B P68371 5/20 0.41
TUBB3 Q13509 5/20 0.41
TUBB2A Q13885 5/20 0.41
TUBB8 Q3ZCM7 5/20 0.41
TUBA3E Q6PEY2 5/20 0.41
TUBA1A Q71U36 5/20 0.41
TUBA1C Q9BQE3 5/20 0.41
TUBB6 Q9BUF5 5/20 0.41
TUBB2B Q9BVA1 5/20 0.41
TUBB1 Q9H4B7 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817877 0.75 PTAFR (0.45) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7817882 0.75 PTAFR (0.45) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7817886 0.75 PTAFR (0.45) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7023416 0.74 PTAFR (0.56) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7023428 0.74 PTAFR (0.56) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7023424 0.74 PTAFR (0.56) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL9371987 0.73 TUBB4A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9203827 0.72 PTAFR (0.50) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7815160 0.70 PTAFR (0.47) PTAFRACHEPTPN1KMT2AMEN1
SCHEMBL7815158 0.70 PTAFR (0.47) PTAFRACHEPTPN1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0334809-B1 Agents for the protection of plants against diseases CIBA GEIGY AG (CH) 1994-06-15 EP claimed
EP-0574510-A4 NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS INNOVATIVE TECH CENTER (US) 1994-07-06 EP disclosed
EP-0574510-A1 NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1993-12-22 EP disclosed
WO-1992015294-A1 NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1992-09-17 WO disclosed